STRO

SUTRO BIOPHARMA INC

STRO·869367201·US·Common Stock·Healthcare - Biotechnology-13D/G

STRO (SUTRO BIOPHARMA INC) is held by 62 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($37.3M), BALYASNY ASSET MANAGEMENT L.P. ($23.6M), VANGUARD CAPITAL MANAGEMENT LLC ($23M). Net institutional sentiment: Bullish.

62
Holders
(3 Elite)
$233.5M
Total Value
70% (67)
Consensus
47 buying - 20 selling
13F: Insider & Congress: Updated regularly
STRO

Smart Money Verdict

View all
Loading verdict
Held by 62 funds
3 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders none · Activists Aug 14, 2026 · Congress none

ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.1.4%Aug 14, 2026
ActivistPAPerceptive Advisors LLC7.9%Aug 14, 2026
ActivistBlackRock, Inc.BlackRock, Inc.6.4%Jul 30, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
1.1M(+382.5%)$37.3M0.0%-29.22%
47
Increased
711,162(+52.7%)$23.6M0.0%-1.52%
40
Decreased
694,219(-3.6%)$23M0.0%+8.78%
0
Increased
458,029(+0.1%)$15.2M0.0%+8.69%
28
Increased
389,692(+127.4%)$12.9M0.0%-48.40%
45
Increased
365,972(+74.0%)$12.2M0.0%+3.65%
42
Increased
305,979(+487.1%)$10.2M0.0%-35.20%
45
New
244,669$8.1M0.0%-35.45%
38
Decreased
237,827(-65.6%)$7.9M0.0%+21.61%
0
Decreased
208,512(-46.9%)$6.9M0.0%+10.01%
0
Increased
201,688(+209.4%)$6.7M0.0%-24.61%
44
New
197,562$6.6M0.0%-35.45%
38
Decreased
175,246(-21.3%)$5.8M0.0%+43.52%
0
New
167,997$5.6M0.0%-35.45%
37
New
159,627$5.3M0.0%-35.45%
37
Increased
149,216(+448.9%)$5M0.0%-30.00%
43
Increased
125,933(+279.7%)$4.2M0.0%-46.24%
43
New
106,610$3.5M0.0%-35.45%
37
Increased
104,232(+9.9%)$3.5M0.0%+2.45%
29
Decreased
101,965(-13.3%)$3.4M0.0%+22.40%
0

Showing 1-20 of 71

1 / 4
STROSTROSUTRO BIOPHARMA INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used